| Dir : /home/ithome/mail/cur/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/cur/1757333383.M158209P4181.host100322.itwesthosting.com,S=17852,W=18170:2, |
Return-Path: <radiology@biomedgrid-el.org>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id IJtPCYfHvmhVEAAAp0YrwQ
(envelope-from <radiology@biomedgrid-el.org>)
for <ithome@host100322.itwesthosting.com>; Mon, 08 Sep 2025 14:09:43 +0200
Return-path: <radiology@biomedgrid-el.org>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Mon, 08 Sep 2025 14:09:43 +0200
Received: from mail-southindiaazon11021112.outbound.protection.outlook.com ([40.107.57.112]:26694 helo=MA0PR01CU012.outbound.protection.outlook.com)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <radiology@biomedgrid-el.org>)
id 1uvagn-00018l-22
for senka.rendulic@bolnica-lipik.hr;
Mon, 08 Sep 2025 14:09:43 +0200
ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none;
b=kOU5r1LgARdxPGHlwTOZWuyGLUhxxNVYh/u8vlLXC+xH8GWuugYMVwABCFk+1jMDlplp3YXSLyDmgetTvGKbdwQ71kSGK7hhiUzxBXxjbwPtCS+ZsVX2/yzxMJUNau50ic5LWJHf86GAemBTGP79ze7S3IY959MK8uGMi6Y3VkjZPeitGvAO5P6tclTL1af7WMN1gwrtcuL8Io/dIiOPQRYuOgZzcjfJBQPV1hUIqOG+YlEgOVaXjFKGI/2ZFm7pKd/DwYEtFKbLCmC5UwTtAKIH92b8a2FqtE0rvwXGZoWsBNCXFTTeKncOY5gfBn2RxySG8DlLTSlVHOtmn4zHlg==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com;
s=arcselector10001;
h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1;
bh=uyyLMqO4SaVHCIWTjeM8d3X7q1Fgf4oskkXdh26OQiU=;
b=PeMl8BwcydtRyUVCbljO2ByvGlAepan9P7Hozc9qpP/fnL6eV3HM0KztqY6iAd9Ojm9mwW6ainqI+ZXUN7ZdGGcCiTs1CqD1eG/m39GWe9w7OZ9Bwws0HGXmp68y67vAueGB6DXqCs6RwH/XiZToJh4ustlG2SyCiEpdSys4BOfkC5foRTbC4z/whXqr+DFT+FNxucIytrAKJqn5KlRzMqnqNyPP9SRq46RedxzaGPRc4NjQtzoHE8QDYpsoXjBlGZz3KhNPEMG7rZAyd7yF5YoeP1iIaZRoFkt0DwOIpG7gNAWWSGLNG3LTGEg7lHkPJq7aKSvle/fiVpCgeTqo2Q==
ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass
smtp.mailfrom=biomedgrid-el.org; dmarc=pass action=none
header.from=biomedgrid-el.org; dkim=pass header.d=biomedgrid-el.org; arc=none
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=biomedgrid-el.org;
s=selector2;
h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck;
bh=uyyLMqO4SaVHCIWTjeM8d3X7q1Fgf4oskkXdh26OQiU=;
b=r9Fi8unE2CdlA9aqql8gW/mzlDqmWPT6Mls0dLwi67IjpkC48IaJRshtn4J8sdcykiynNaBeIpBx4IJSiaSlDKZNmcGKsFxS2RS85/JT6D0AynP1AMzHgiM44SOemvDnB91Ld7y1q02F5R30h9aUHaLfxMQcgl3DMSxGblHetTT1+OM4lgGNBEsXDaruyeLpK0jQFwMO5eInYwwMJQX1yUQ5pu6huXzxRyCe1+DO6exx7duZqiicExDpsC8rbz23aZw7GNA55GHxd8HiGdCHwh2Yf6PvivfaKICH0qX66yNgFmrgoyaFaCli1vikmd/dorphrbVwYc0Jzcl+eVQKJA==
Received: from PN3P287MB1620.INDP287.PROD.OUTLOOK.COM (2603:1096:c01:19e::5)
by MA0P287MB0313.INDP287.PROD.OUTLOOK.COM (2603:1096:a01:b2::13) with
Microsoft SMTP Server (version=TLS1_2,
cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9094.22; Mon, 8 Sep
2025 12:09:36 +0000
Received: from PN3P287MB1620.INDP287.PROD.OUTLOOK.COM
([fe80::b4b:b72e:dbd:2eb3]) by PN3P287MB1620.INDP287.PROD.OUTLOOK.COM
([fe80::b4b:b72e:dbd:2eb3%5]) with mapi id 15.20.9094.018; Mon, 8 Sep 2025
12:09:35 +0000
From: "American Journal of Biomedical Science & Research"
<radiology@biomedgrid-el.org>
To: "senka.rendulic@bolnica-lipik.hr" <senka.rendulic@bolnica-lipik.hr>
Subject: Re: Supportive comeback
Thread-Topic: Re: Supportive comeback
Thread-Index: AdwguXDEBV177Ez1TxOH6Du+O+5LpA==
Date: Mon, 8 Sep 2025 12:09:35 +0000
Message-ID:
<PN3P287MB16207713250A62D062E47DD2F60CA@PN3P287MB1620.INDP287.PROD.OUTLOOK.COM>
Accept-Language: en-US
Content-Language: en-US
X-MS-Has-Attach:
X-MS-TNEF-Correlator:
authentication-results: dkim=none (message not signed)
header.d=none;dmarc=none action=none header.from=biomedgrid-el.org;
x-ms-publictraffictype: Email
x-ms-traffictypediagnostic: PN3P287MB1620:EE_|MA0P287MB0313:EE_
x-ms-office365-filtering-correlation-id: 3ec6fa23-1a92-4f40-7d10-08ddeed093f2
x-ms-exchange-senderadcheck: 1
x-ms-exchange-antispam-relay: 0
x-microsoft-antispam:
BCL:0;ARA:13230040|10070799003|1800799024|366016|376014|8096899003|38070700018;
x-microsoft-antispam-message-info:
=?us-ascii?Q?9T4gsxFkloGX0pbpu5uZqvcIevAoCR+KYUjaegVjkixdvHFJ2bY9Kmdz4nl8?=
=?us-ascii?Q?3xk3y7Zahy6zLUzg6mNrodc5PYPPpqTDVBiBn7NyNNsB0478Yxyu3jpIV7RD?=
=?us-ascii?Q?v07upT3lrEq2gfPYOHG1kZ20XW0K6iqW7684BmmyBHz3Tb3b9eyzYWihoAcO?=
=?us-ascii?Q?uQ+16XX38C6rR+3K+ZBJWd7cAbmNh1CJnri7E7xqIWSJsMcy1QRHyZOBIvNT?=
=?us-ascii?Q?df311y/SdRi0JUZSOYpJX/Pr/tLUmCyy8ZeVNrkfOWjwVe8AWnlwrron3rnP?=
=?us-ascii?Q?fN/J6RTJolEZefZJ7yTYv+SAjZehhKJH0xhMgLTYp3+A2L9VejnRbciRr/XT?=
=?us-ascii?Q?GnAvA00vgD5b3T74UDDAXN/P3jV9dZGXNh+C2pkElUO4IxjX+U8SbGFktAgM?=
=?us-ascii?Q?9p/PE9mMhEHr+USpO1w51f9ifg25JaDEKFlS+LvaIMPiG+kgxX+TPjjAfBRr?=
=?us-ascii?Q?OQYZpDkVzgzxRiEh8qp1sv31hDtWZ8HHpOU5ivb8jcWHDZtyiw/6R36VVUt9?=
=?us-ascii?Q?UWtZqmrAAxjSSB7sl4W2wjtrv4CSc7FhHeMe/ha2ZHE0zfBf0XfXMvppzYJq?=
=?us-ascii?Q?9dAFoxTgkjZZMOHDJceICRh7iHSWwMB15M1IFnXNHo6/t/3uDgCdEYOaHFu+?=
=?us-ascii?Q?zU7B5BPM57Dl7kGUdHuX41Rfle9uURd4YKEAzIC4b20sdM5FSEGP6OHbZClc?=
=?us-ascii?Q?FAGGx5PbQy/bhwm95NLeiS5SiXuIAuE4JqIGNHl5+q4sVwfA2yWf56c7dLlg?=
=?us-ascii?Q?AD9FKm0BHI3SS0gOTe2/6nX2RDYlS8AZvesD1haBe3sB4cFDuaXLimGU1Lhe?=
=?us-ascii?Q?AZKELDRLoMz79y529rEd/bIIzi3o8/RBFzXaS8CX9ll1TmdMXhveKRp3nYbk?=
=?us-ascii?Q?fNnxEUeiZT4ju6IZpVakOn3U0/hCd/I7bDuY2HydczBSYcPbvm3NvMZrTy9E?=
=?us-ascii?Q?sgkhTDvtG68a0jHailk9H9NE+lt6+PvrNRmhFatN+kINBzaTFbOl0ICcMzbx?=
=?us-ascii?Q?As5U1lDs7AxV3CnsbEdiBHacPd6H9NT3CurLDmoDkXVQw95GgWnNrRbsAc66?=
=?us-ascii?Q?ymvyHORS70P+gAqudfADPWNHBEAaYVX8pyCD+cPgXkNXlWiXnnwRgLS7yMlG?=
=?us-ascii?Q?VRAnbSKJPkE0G9BUUZ4tOZabS+RiDmrCmFJNLK7KQrA/gZekQ3+Jx81kHQ0Q?=
=?us-ascii?Q?Sudll4/EfEVPDbQ0GbaK8vHzf7Yqx5u+Yq1GxtWjsXzk04u83vTVCPoGnahD?=
=?us-ascii?Q?igH59PfbCsPvO/aH3yj1f/Q/NBdv2LAjqbOxoMUOb4F34XoiTcRLjGPt6R4r?=
=?us-ascii?Q?18dJOUphmHlsh1n+srIT1lcfK9gIoB1ZkPH5QvoJ1TTzFvOa6nyR0V4hGZqs?=
=?us-ascii?Q?SdO82mckNDjyPkprN/XvEBCq5MAogUNCWq6q7LXgYnlEadYgC8u/2mWbokcH?=
=?us-ascii?Q?oQAyYX7LUCuXCKqCVidxUN/GprUZiynrudo1vQ4CoQ0spQsSJfXGqA=3D=3D?=
x-forefront-antispam-report:
CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:PN3P287MB1620.INDP287.PROD.OUTLOOK.COM;PTR:;CAT:NONE;SFS:(13230040)(10070799003)(1800799024)(366016)(376014)(8096899003)(38070700018);DIR:OUT;SFP:1102;
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0:
=?us-ascii?Q?q2XP39aA39qIMnTTEdFWHM5k9a6yfNOaGSql01uGxoGdeBMPUkdTJsKBNmKG?=
=?us-ascii?Q?VusbPd+G1drl5WRoMfWlKQi4cJFzim22iVSkePafQF422M80a4F0jCLIUBn6?=
=?us-ascii?Q?hkgprnbuuEKZ9lwB2zGaYZlaFh3donokB2qMuwS3Z/LVX+sFjrJqWFmuNY9T?=
=?us-ascii?Q?IfrYCJug/0evG9PFi91Ek2e/m9rtpUbZjxHzNQX9eN1rsXp8JiuUibgFlTzO?=
=?us-ascii?Q?FfPacavuGSJZ8tCFIO7Q5GyovHcEkmkQRXpPG8ymiWPGso+aOdfe3MIDZTMp?=
=?us-ascii?Q?M7F8BeekJ22Or56qbwVHHKUYCO2Y63KC9G35zEmPP69avdg2OFS0kQqDCC0x?=
=?us-ascii?Q?jZeGirisjW1gI8if/mopJfHQLk/ce8c1fekVmry7qHCBiABZlzl0ZvA4RHZe?=
=?us-ascii?Q?dfksCrWZAcS51jgHk0ouj5ksSNrLDYVUAZ6Q/WyKpQNWE9HwRM4lxT+yINwU?=
=?us-ascii?Q?YInJjuJX62sczi0+dq4AebPw35/LVWynsQNymZwStzXZhx4HTusV/hLfndWG?=
=?us-ascii?Q?XSETjwTtcrxDeap2LEj6wAwd9efjiNAxYo9fYagF8kN6Kb3n4I6E36d2W7hd?=
=?us-ascii?Q?f85wJ5GGX1DIQx5XRjKu2ShZw6XTuz3HDXiurbQb1LF/i/iugp6c081RfxDR?=
=?us-ascii?Q?6f4Fh4XI2OIZpA3i9LmHMRvtSJ/5CEP+P9/pSGp7OjwocyVpwb3pYcyltSVU?=
=?us-ascii?Q?LMNVDGyA90pEbueDoiL+zHyulOzFAM7cPowG8xAAb+aDp0KQ00CI/274eLjf?=
=?us-ascii?Q?8xRektszws5Cwwm96umcLvhrlMZfoUooCLWYb9jFT5bFfBCzF9kxxuAOsBUr?=
=?us-ascii?Q?uHKJZwRiqnmGUHKCyFw22AUb5O9gB6EjGFIJig84bbCgwe76K0z8Ulzhcxvi?=
=?us-ascii?Q?MHXWRQ0XjnJ1QVGaLmRgKBGxEYtq6AajPIbp4flX9P7LOSj3uFnVkTERkY43?=
=?us-ascii?Q?9eofVzdltOS4nvLlnLAJZU6vlswwnqPvIT+vB5/YGqxjGDsVLRK3ln+8UB2p?=
=?us-ascii?Q?LDRGaQ5+KOMhcu7Lg34uDbAQTGgG28THzTEjtJ0c7logM6rkLtfJe+Tu9Oa4?=
=?us-ascii?Q?5rkC7+iSwujz6T8zaP9brIMuWHls8o3lEWAXnZVe4S0sMl3vDoAQN/cFDBpf?=
=?us-ascii?Q?uy9Ri+vyUn3rW7QDiK4XkrwF8K+RveiRV38brpi5a0QHOhMrh4QU32gq/MaT?=
=?us-ascii?Q?upZgJIl21qRmNI1AeiplhW4+/2owlHLLOINQgV6clC478+ib1XTiIZT8liR3?=
=?us-ascii?Q?6Preb//jysLbyA9hsjUjW8bASqoN8w8cBBNbNzNsW4BNB4YROHzYV+DJdtBK?=
=?us-ascii?Q?DgqeVgaKx9XIE4US7WjZ24VwCT7nmGkm4VnheglPYdAxr0JtkSEWVn2Wck+d?=
=?us-ascii?Q?so7e8yZ9OF2hHsmPyw6MNc6/S4AoIKA4A7x6AchABCpHmSAoT/0RrmFwh1IG?=
=?us-ascii?Q?e774PTwTIN/7nHMQ0GaPn/04GmDs0U79f+Vx0cn9TQOLjlAdxKameAnejgmR?=
=?us-ascii?Q?PKPLbGwJRPig1ve7e4WIiGv96bSXaAp7evkIoklk7OdWKA9aHAh5dscVYYam?=
=?us-ascii?Q?XucLVyDtqCHCRJm9tDutacdYLvdJU3AE/kU1yo3wZKMZulfaxQ0YHieJFAT2?=
=?us-ascii?Q?77Y5elecj7K9WKlVLkauOc934xi6S0iUBnPsb2xRU8XD?=
Content-Type: multipart/alternative;
boundary="_000_PN3P287MB16207713250A62D062E47DD2F60CAPN3P287MB1620INDP_"
MIME-Version: 1.0
X-OriginatorOrg: biomedgrid-el.org
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: PN3P287MB1620.INDP287.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-Network-Message-Id: 3ec6fa23-1a92-4f40-7d10-08ddeed093f2
X-MS-Exchange-CrossTenant-originalarrivaltime: 08 Sep 2025 12:09:35.8877
(UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 45d07865-27e1-46e6-ba1a-878dd4392f2c
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: dQii4Z4hZk6FhwKis5yO7Dt6Pdk0H1is/ePskNcDtGSr8Bi2WsRF7dGloTKQ0UINMCWOFxZLxVaEuIlpZXPHc2wttn+WQwqf9kDHGnVwA8c=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: MA0P287MB0313
X-Spam-Status: No, score=-0.2
X-Spam-Score: -1
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Dear Professor, Warm greetings from the American Journal of
Biomedical Science & Research (AJBSR)! We are currently preparing Volume
28, Issue 3 and would be honoured to include a 2-page Opinion Piece or Mini
Review from you. Your insights would be a valuable addition to this upcoming
issue.
Content analysis details: (-0.2 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[40.107.57.112 listed in bl.score.senderscore.com]
-0.0 SPF_PASS SPF: sender matches SPF record
-0.0 SPF_HELO_PASS SPF: HELO matches SPF record
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[40.107.57.112 listed in sa-accredit.habeas.com]
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: biomedgrid-el.org]
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
--_000_PN3P287MB16207713250A62D062E47DD2F60CAPN3P287MB1620INDP_
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable
Dear Professor,
Warm greetings from the American Journal of Biomedical Science & Research (=
AJBSR)!
We are currently preparing Volume 28, Issue 3 and would be honoured to incl=
ude a 2-page Opinion Piece or Mini Review from you. Your insights would be =
a valuable addition to this upcoming issue.
Thank you for considering our invitation.
We look forward to your response!
Nancy Perez
Assistant Managing Editor
ISSN: 2642-1747 | Impact Factor: 2.409
Tel: +1 (626) 698-0574
BioMed Grid LLC, California, USA. If you do not wish to receive this email,=
reply to us.
--_000_PN3P287MB16207713250A62D062E47DD2F60CAPN3P287MB1620INDP_
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable
<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-micr=
osoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"http:=
//www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii"=
>
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin-top:0cm;
margin-right:0cm;
margin-bottom:8.0pt;
margin-left:0cm;
line-height:107%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-ligatures:standardcontextual;
mso-fareast-language:EN-US;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
.MsoPapDefault
{mso-style-type:export-only;
margin-bottom:8.0pt;
line-height:107%;}
@page WordSection1
{size:595.3pt 841.9pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=3D"EN-IN" style=3D"word-wrap:break-word">
<div class=3D"WordSection1">
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><b><s=
pan lang=3D"EN-US" style=3D"font-size:10.0pt;font-family:"Verdana"=
;,sans-serif">Dear Professor,<o:p></o:p></span></b></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><b><s=
pan lang=3D"EN-US" style=3D"font-size:10.0pt;font-family:"Verdana"=
;,sans-serif"><o:p> </o:p></span></b></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif">Warm=
greetings from the
<i><span style=3D"color:#0070C0">American Journal of Biomedical Science &am=
p; Research (AJBSR)</span></i><span style=3D"color:#0070C0">!</span><o:p></=
o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif"><o:p=
> </o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif">We a=
re currently preparing
<span style=3D"color:#ED7D31">Volume 28, Issue 3 </span>and would be honour=
ed to include
<span style=3D"color:#00B050">a <i>2-page Opinion Piece or Mini Review</i><=
/span> from you. Your insights would be a valuable addition to this upcomin=
g issue.<o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif"><o:p=
> </o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif">Than=
k you for considering our invitation.<o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif"><o:p=
> </o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif">We l=
ook forward to your response!<o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif"><o:p=
> </o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><b><s=
pan style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif;co=
lor:#7030A0">Nancy Perez</span></b><span style=3D"font-size:10.0pt;font-fam=
ily:"Verdana",sans-serif;color:#7030A0"><br>
Assistant Managing Editor<br>
ISSN: 2642-1747 | Impact Factor: 2.409<br>
Tel: +1 (626) 698-0574<o:p></o:p></span></p>
<p class=3D"MsoNormal" style=3D"margin-bottom:0cm;line-height:normal"><span=
style=3D"font-size:10.0pt;font-family:"Verdana",sans-serif;color=
:#7030A0"><o:p> </o:p></span></p>
<p class=3D"MsoNormal" align=3D"center" style=3D"margin-bottom:0cm;text-ali=
gn:center;line-height:normal">
<span style=3D"font-size:8.0pt;font-family:"Verdana",sans-serif;c=
olor:#BFBFBF">BioMed Grid LLC, California, USA. If you do not wish to recei=
ve this email, reply to us.<o:p></o:p></span></p>
</div>
</body>
</html>
--_000_PN3P287MB16207713250A62D062E47DD2F60CAPN3P287MB1620INDP_--